The objective of this study was to present evidence on the epidemiology, health outcomes
and economic burden of cancer-related venous thromboembolism (VTE). Medline …

Aims A Markov model was adapted to assess the real-world cost-effectiveness of
rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral …

Emerging evidence shows that the recent pandemic of coronavirus disease 19 (COVID-19)
is characterized by coagulation activation and endothelial dysfunction. This increases the …

Abstract Introduction In 2011, the American Academy of Orthopaedic Surgeons released a
consensus recommending venous thromboembolism (VTE) prophylaxis after total knee …

In 2010, we proposed the first Korean Guidelines for the Prevention of Venous
Thromboembolism (VTE). It was applicable to Korean patients, by modifying the contents of …

Background Venous thromboembolism (VTE) is a burden on healthcare systems. Standard
treatment involves parenteral anticoagulation overlapping with a vitamin K antagonist, an …

Abstract Background Both midline catheters (MCs) and peripherally inserted central
catheters (PICCs) can cause venous thromboembolism (VTE), but the prevalence …

Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary
embolism, is a major clinical concern associated with significant morbidity and mortality. The …

Background: Calf muscle venous thrombosis (CMVT) is among the most important medical
complications after hip surgery. CMVT has been known for many years, but many opinions …

Objective: To identify the optimal timing of perioperative chemical thromboprophylaxis (CTP)
and incidence of occult preoperative deep vein thrombosis (OP-DVT) in patients undergoing …